Nicholas Lydon
For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition.
Affiliated at time of winning
Basel, Switzerland
Recognition for work with lasting impact
For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition.
Basel, Switzerland